James P. Allison

Has grant

Professor and Chair

The University of Texas MD Anderson Cancer Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Delineating the role of the microbiome in modulating tumor & host immunity

Open Date: 2017-07-01

Close Date: 2020-06-30

Grant: Close

Immunologic Checkpoint Blockade in Cancer Therapy

Open Date: 2012-10-01

Close Date: 2015-09-30

Grant: Close

Defining the Importance of Immunity to NY-ESO-1 in Melanoma

Open Date: 2009-09-01

Close Date: 2012-08-31

Grant: Close

Therapeutic Inhibition of mutant activated signaling pathways in melanoma

Open Date: 2008-07-01

Close Date: 2011-06-30

Grant: Close

Inducing efficacious anti-tumor T cell responses through PD-1 and Tim-3 blockade

Open Date: 2008-05-01

Close Date: 2011-04-30

Articles (23)

Table S6. Gene set enrichment analysis using the KEGG pathways and Gene Ontology Biological Processes databases. Pathways statistically significant activated or suppressed after twelve months exercise are displayed (BH-adjusted P-value

Year:

2025

Table S2. Number of Patients Experiencing Adverse Events by Maximum Grade consent and initiation of exercise regimen (Pre-Study) and in the exercise and usual care group. List with the number of patients experiencing adverse events. Should a patient experience any adverse event, the patient is counted only at the highest (maximum) grade experienced.

Year:

2025

Figure S5. (A) Gene Set Enrichment Analysis (GSEA) of BIOCARTA IL-6 pathway; (B) Gene set of IL-6-stimulated cell cultures; (C) Gene set in IL-6-deprived cell cultures. GSEA was performed by 1000 permutations. The maximum and minimum sizes for gene sets were 500 and 15, respectively. The y-axis represents the enrichment score (ES) and the x-axis lists the ranked genes by fold change. Vertical black lines on the x-axis represent the genes in gene sets. The green line connects points of ES and genes. ES is the maximum deviation from zero as calculated for each gene going down the ranked list and represents the degree of over-representation of a gene set at the top or the bottom of the ranked gene list. The P-value and ES are labeled at the top of the figure. The peak towards to left of the x-axis suggests a positive enrichment of the target gene set and vice versa.

Year:

2025

Table S3. Number of patients experiencing adverse events. Only those toxicities experienced while on the trial are presented in the table. Toxicities during the pre-study stage of the trial, for example, that were present before participants begin intervention were not included. Should a patient experience an adverse event more than once, the patient is only counted once at the highest grade for that adverse event.

Year:

2025

Table S1. Adverse events (AEs) experience by participants with possible or probable relation to the study intervention. Summary of the adverse events by grade, relationship, and arm. Adverse events were reported by subjects, including AEs that happened between consent and initiation of exercise regimen (Pre-Study) and in the exercise and usual care group.

Year:

2025

Figure S4. Relative change in prostaglandin metabolite levels after twelve months follow-up in usual care and exercise groups (A-C, Wilcoxon signed-rank test; ns, P>0.05; *, P ≤0.05; **, P≤0.01).

Year:

2025

Figure S3. (A) Average time that study participants wore the Fitbit throughout the study; (B) Resting heart rate in study participants at baseline; (C) Average total minutes of exercise at heart rate 70-85% of PHR; (D) Average total minutes of exercise at heart rate >85% of PHR. (***, P ≤0.001; ****, P≤0.0001).

Year:

2025

Figure S8. (A) Volcano plot of statistically significant genes and fold-changes between the usual care and exercise groups in DSP assay. Top significantly differentially expressed genes are labeled; (B) The dot plot presents enriched GSEA HALLMARK pathways. The sizes of the dots represent the count of core enrichment (leading-edge) genes. The colors of the dots represent the BH-adjusted P-values. The order of HALLMARK gene sets is based on the gene ratio (number of significant genes associated with the HALLMARK gene sets / total number of significant genes; (C) Total CD8+ T cell density per mm2 (left) and epithelial (right) in colonic mucosa preand post- intervention from usual care (n=4) and exercise (n=4) participants; (D) Total CD57+ NK cell density per mm2 (left) and epithelial (right) in colonic mucosa pre- and post- intervention from usual care (n=4) and exercise (n=4) participants.

Year:

2025

Figure S6. Deconvolution of immune cell types by CIBERSORT. Changes in deconvoluted immune cell type proportions derived from mRNAseq data are shown after twelve months of follow-up in the usual care (N=6) and exercise (N=9) groups using CIBERSORT. No significant changes in immune cell types were observed, though CD8+ T cells were non-statistically significantly higher in the exercise group (two-tail Wilcoxon signed-rank test).

Year:

2025

Purpose: Lynch syndrome (LS) is a hereditary condition with a high lifetime risk of colorectal and endometrial cancers. Exercise is a non-pharmacologic intervention to reduce cancer risk, though its impact on patients with LS has not been prospectively studied. Here, we evaluated the impact of a 12-month aerobic exercise cycling intervention in the biology of the immune system in LS carriers. Patients and Methods: To address this, we enrolled 21 patients with LS onto a non-randomized, sequential intervention assignation, clinical trial to assess the effect of a 12-month exercise program that included cycling classes 3 times weekly for 45 minutes versus usual care with a one-time exercise counseling session as control. We analyzed the effects of exercise on cardiorespiratory fitness, circulating, and colorectal-tissue biomarkers using metabolomics, gene expression by bulk mRNA sequencing, and spatial transcriptomics by NanoString GeoMx. Results: We observed a significant increase in oxygen consumption (VO 2peak ) as a primary outcome of the exercise and a decrease in inflammatory markers (prostaglandin E) in colon and blood as the secondary outcomes in the exercise versus usual care group. Gene expression profiling and spatial transcriptomics on available colon biopsies revealed an increase in the colonic mucosa levels of natural killer and CD8 + T cells in the exercise group that were further confirmed by IHC studies. Conclusions: Together these data have important implications for cancer interception in LS, and document for the first-time biological effects of exercise in the immune system of a target organ in patients at-risk for cancer.

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (33)

Karen Basen-Engquist

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Cezar Iliescu

Professor of Medicine, Interventional Cardiology

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Chad Huff

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Meenakshi Bhattacharjee

Professor & Director of Neuropathology

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Johannes Fahrmann

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Erika Yanil Faraoni

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Yisheng LI

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Christopher J. Logothetis

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Louis Maximilian Buja

Professor

The University of Texas Health Science Center at Houston

UNITED STATES
View details

Florencia McAllister

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Susan C. Gilchrist

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Samir M. Hanash

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Paul Corn

Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Yibo Dai

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Eduardo Vilar

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Patrick Lynch

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Paul Viscuse

Assistant Professor

University of Virginia

UNITED STATES
View details

Miao Zhang

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jennifer A. Wargo

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Sreyashi Basu

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Nicolas Palaskas

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Manoj Chelvanambi

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ana Aparicio

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Seyed Javad Moghaddam

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Sumit Subudhi

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Ernest Hawk

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Alexander Lazar

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Wenyi Wang

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Christina Dieli-Conwright

Dana-Farber Cancer Institute

UNITED STATES
View details

Anita Deswal

Department Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Linghua Wang

Executive Director & Head

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Guillermina Lozano

Professor and Chair

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jay Kolls

Professor

Tulane University School of Medicine

UNITED STATES
View details